Neurologic Disorders Due to Mitochondrial DNA Mutations

Seminars in Pediatric Neurology

Volumn 19, Issue 4, 2012, Pages 194-202

  DeBrosse, Suzanne ^a   Parikh, Sumit ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ARGININE; ASPARTIC ACID; BEZAFIBRATE; MITOCHONDRIAL DNA;

ARTICLE; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENETIC ASSOCIATION; HEARING AID; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MATERNALLY INHERITED DIABETES AND DEAFNESS; MELAS SYNDROME; MERRF SYNDROME; NARP SYNDROME; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PEARSON SYNDROME;

DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; MUTATION; NERVOUS SYSTEM DISEASES; OPTIC NERVE DISEASES;

EID: 84870937132     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2012.09.006     Document Type: Article

References (124)

1. Kaufmann P., Engelstad K., Wei Y., et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 2006, 66:324-330.
2. Pitceathly R.D., Fassone E., Taanman J.W., et al. Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J Med Genet 2011, 48:610-617.
3. Pearson H.A., Lobel J.S., Kocoshis S.A., et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979, 95:976-984.
4. Williams T.B., Daniels M., Puthenveetil G., et al. Pearson syndrome: Unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. Mol Genet Metab 2012, 106:104-107.
5. Rotig A., Cormier V., Blanche S., et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990, 86:1601-1608.
6. Lee H.F., Lee H.J., Chi C.S., et al. The neurological evolution of Pearson syndrome: Case report and literature review. Eur J Paediatr Neurol 2007, 11:208-214.
7. McShane M.A., Hammans S.R., Sweeney M., et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991, 48:39-42.
8. DiMauro S., Hirano M., Mitochondrial D.N.A. Deletion syndromes. GeneReviews 1993, University of Washington, Seattle, WA. R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam (Eds.).
9. Berenberg R.A., Pellock J.M., DiMauro S., et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome?. Ann Neurol 1977, 1:37-54.
10. Kornblum C., Broicher R., Walther E., et al. Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology 2001, 56:1409-1412.
11. Spector R., Johanson C.E. Choroid plexus failure in the Kearns-Sayre syndrome. Cerebrospinal Fluid Res 2010, 7:14.
12. Lax N.Z., Campbell G.R., Reeve A.K., et al. Loss of myelin-associated glycoprotein in Kearns-Sayre syndrome. Arch Neurol 2012, 69:490-499.
13. Emma F., Bertini E., Salviati L., et al. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 2012, 27:539-550.
14. Schon E.A. Rearrangements of mitochondrial DNA. Genetics of Mitochondrial Diseases 2003, 111-124. Oxford University Press, Oxford, UK. I.J. Holt (Ed.).
15. Poulton J., Deadman M.E., Gardiner R.M. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1989, 1:236-240.
16. Emmanuele V., Silvers D.S., Sotiriou E., et al. MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T>C mutation. Muscle Nerve 2011, 44:448-451.
17. Ogasahara S., Nishikawa Y., Yorifuji S., et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986, 36:45-53.
18. Rowland L. Progressive External Opthalmoplegia. Handb Clin Neurol 1975, 22:177-202.
19. Aure K., Ogier de Baulny H., Laforet P., et al. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: Can we predict progression?. Brain 2007, 130:1516-1524.
20. Agostino A., Valletta L., Chinnery P.F., et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003, 60:1354-1356.
21. Pfeffer G., Sirrs S., Wade N.K., et al. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 2011, 38:119-123.
22. Smits B.W., Heijdra Y.F., Cuppen F.W., et al. Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol 2011, 258:2020-2025.
23. Ballinger S.W., Shoffner J.M., Hedaya E.V., et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992, 1:11-15.
24. Massin P., Guillausseau P.J., Vialettes B., et al. Macular pattern dystrophy associated with a mutation of mitochondrial DNA. Am J Ophthalmol 1995, 120:247-248.
25. Guillausseau P.J., Massin P., Dubois-LaForgue D., et al. Maternally inherited diabetes and deafness: A multicenter study. Ann Intern Med 2001, 134:721-728.
26. Reardon W., Ross R.J., Sweeney M.G., et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992, 340:1376-1379.
27. Schulz J.B., Klockgether T., Dichgans J., et al. Mitochondrial gene mutations and diabetes mellitus. Lancet 1993, 341:438-439.
28. Donovan L.E., Severin N.E. Maternally inherited diabetes and deafness in a North American kindred: Tips for making the diagnosis and review of unique management issues. J Clin Endocrinol Metab 2006, 91:4737-4742.
29. Laloi-Michelin M., Meas T., Ambonville C., et al. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 2009, 94:3025-3030.
30. Ballinger S.W., Shoffner J.M., Gebhart S., et al. Mitochondrial diabetes revisited. Nat Genet 1994, 7:458-459.
31. Martin Negrier M.L., Coquet M., Moretto B.T., et al. Partial triplication of mtDNA in maternally transmitted diabetes mellitus and deafness. Am J Hum Genet 1998, 63:1227-1232.
32. Velho G., Byrne M.M., Clement K., et al. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 1996, 45:478-487.
33. Olmos P.R., Borzone G.R., Olmos J.P., et al. Mitochondrial diabetes and deafness: Possible dysfunction of strial marginal cells of the inner ear. J Otolaryngol Head Neck Surg 2011, 40:93-103.
34. Maassen J.A. Mitochondrial diabetes: Pathophysiology, clinical presentation, and genetic analysis. Am J Med Genet 2002, 115:66-70.
35. Suzuki S., Hinokio Y., Ohtomo M., et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998, 41:584-588.
36. Buchan J.C., Ong C., Dabbs T.R. Acute leber hereditary optic neuropathy in a 73-year-old man. Eye (Lond) 2007, 21:859-860.
37. Leber hereditary optic neuropathy. GeneReviews -[PubMed-NCBI], 1993 Available at: Accessed July 7, 2012. http://www.ncbi.nlm.nih.gov/pubmed?term=20301353.
38. Horvath R., Abicht A., Shoubridge E.A., et al. Leber's hereditary optic neuropathy presenting as multiple sclerosis-like disease of the CNS. J Neurol 2000, 247:65-67.
39. Kellar-Wood H., Robertson N., Govan G.G., et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994, 36:109-112.
40. Palace J. Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy. J Neurol Sci 2009, 286:24-27.
41. Morimoto N., Nagano I., Deguchi K., et al. Leber hereditary optic neuropathy with chorea and dementia resembling Huntington disease. Neurology 2004, 63:2451-2452.
42. Nikoskelainen E.K., Marttila R.J., Huoponen K., et al. Leber's "plus": Neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995, 59:160-164.
43. Mnatsakanyan L., Ross-Cisneros F.N., Carelli V., et al. Axonal degeneration in peripheral nerves in a case of Leber hereditary optic neuropathy. J Neuroophthalmol 2011, 31:6-11.
44. Carelli V., Valentino M.L., Liguori R., et al. Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: Report of two cases. J Neurol Neurosurg Psychiatry 2001, 71:813-816.
45. Spruijt L., Smeets H.J., Hendrickx A., et al. A MELAS-associated ND1 mutation causing leber hereditary optic neuropathy and spastic dystonia. Arch Neurol 2007, 64:890-893.
46. Tarnopolsky M.A., Baker S.K., Myint T., et al. Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation. Am J Med Genet A 2004, 124A:372-376.
47. De Vries D.D., Went L.N., Bruyn G.W., et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996, 58:703-711.
48. Gropman A., Chen T.J., Perng C.L., et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A 2004, 124A:377-382.
49. Nikoskelainen E.K., Savontaus M.L., Huoponen K., et al. Lancet 1994, 344:857-858.
50. Spruijt L., Kolbach D.N., de Coo R.F., et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol 2006, 141:676-682.
51. Johns D.R., Heher K.L., Miller N.R., et al. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993, 111:495-498.
52. Johns D.R., Smith K.H., Miller N.R. Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol 1992, 110:1577-1581.
53. Blakely E.L., de Silva R., King A., et al. LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation. Eur J Hum Genet 2005, 13:623-627.
54. Bu X.D., Rotter J.I. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A 1991, 88:8198-8202.
55. Hudson G., Keers S., Yu Wai Man P., et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 2005, 77:1086-1091.
56. Ji Y., Jia X., Li S., et al. Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese. Mol Vis 2010, 16:416-424.
57. Shankar S.P., Fingert J.H., Carelli V., et al. Evidence for a novel X-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet 2008, 29:17-24.
58. Chalmers R.M., Davis M.B., Sweeney M.G., et al. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet 1996, 59:103-108.
59. Giordano C., Montopoli M., Perli E., et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011, 134:220-234.
60. Howell N., Herrnstadt C., Shults C., et al. Low penetrance of the 14484 LHON mutation when it arises in a non-haplogroup J mtDNA background. Am J Med Genet A 2003, 119A:147-151.
61. Hudson G., Carelli V., Spruijt L., et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 2007, 81:228-233.
62. Newman N.J., Lott M.T., Wallace D.C. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991, 111:750-762.
63. Sadun F., De Negri A.M., Carelli V., et al. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2004, 137:271-277.
64. Beretta S., Mattavelli L., Sala G., et al. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 2004, 127:2183-2192.
65. Danielson S.R., Wong A., Carelli V., et al. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-induced apoptosis. J Biol Chem 2002, 277:5810-5815.
66. Kirkman M.A., Yu-Wai-Man P., Korsten A., et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009, 132:2317-2326.
67. Sadun A.A., Carelli V., Salomao S.R., et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003, 136:231-238.
68. Kerrison J.B., Miller N.R., Hsu F., et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol 2000, 130:803-812.
69. Carelli V., Franceschini F., Venturi S., et al. Grand rounds: Could occupational exposure to n-hexane and other solvents precipitate visual failure in leber hereditary optic neuropathy?. Environ Health Perspect 2007, 115:113-115.
70. Qi X., Sun L., Hauswirth W.W., et al. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol 2007, 125:268-272.
71. Klopstock T., Yu-Wai-Man P., Dimitriadis K., et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 2011, 134:2677-2686.
72. Mashima Y., Kigasawa K., Wakakura M., et al. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?. J Neuroophthalmol 2000, 20:166-170.
73. Qi X., Lewin A.S., Sun L., et al. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 2004, 56:182-191.
74. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol [PubMed - NCBI], 2012. Available at: Accessed July 21, 2012. http://www.ncbi.nlm.nih.gov/pubmed?term=22410442.
75. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951, 14:216-221.
76. Rahman S., Blok R.B., Dahl H.H., et al. Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann Neurol 1996, 39:343-351.
77. Thorburn D.R., Rahman S., Mitochondrial D.N.A.- Associated Leigh Syndrome and NARP. GeneReviews 1993, University of Washington, Seattle, WA. R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam (Eds.).
78. Subacute necrotizing encephalomyelopathy Gen Diagn Pathol. [PubMed-NCBI], 1997. Available at: Accessed July 21, 2012. http://www.ncbi.nlm.nih.gov/pubmed?term=9228257.
79. Leshinsky-Silver E., Levine A., Nissenkorn A., et al. Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency. Mol Genet Metab 2003, 79:288-293.
80. Kirby D.M., Boneh A., Chow C.W., et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol 2003, 54:473-478.
81. Shoffner J.M., Fernhoff P.M., Krawiecki N.S., et al. Subacute necrotizing encephalopathy: Oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 1992, 42:2168-2174.
82. Santorelli F.M., Tanji K., Shanske S., et al. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology 1997, 49:270-273.
83. Santorelli F.M., Mak S.C., Vazquez-Memije M.E., et al. Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996, 39:914-917.
84. Goldenberg P.C., Steiner R.D., Merkens L.S., et al. Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency. Neurology 2003, 60:865-868.
85. Bastin J., Aubey F., Rotig A., et al. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J Clin Endocrinol Metab 2008, 93:1433-1441.
86. Wenz T., Diaz F., Spiegelman B.M., et al. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 2008, 8:249-256.
87. Alexeyev M.F., Venediktova N., Pastukh V., et al. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes. Gene Ther 2008, 15:516-523.
88. Bayona-Bafaluy M.P., Blits B., Battersby B.J., et al. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci U S A 2005, 102:14392-14397.
89. Sgarbi G., Casalena G.A., Baracca A., et al. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy. Arch Neurol 2009, 66:951-957.
90. Melegh B., Trombitas K. Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle. Neuropediatrics 1997, 28:257-261.
91. Anderson C.M., Norquist B.A., Vesce S., et al. Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death. J Neurosci 2002, 22:9203-9209.
92. Shear T., Tobias J.D. Anesthetic implications of Leigh's syndrome. Paediatr Anaesth 2004, 14:792-797.
93. Stacpoole P.W., Gilbert L.R., Neiberger R.E., et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 2008, 121:e1223-8.
94. Dichloroacetate therapy in Leigh syndrome with a mitochondrial T8993C mutation. Pediatr Neurol-[PubMed-NCBI], 2002. Available at: Accessed July 21, 2012. http://www.ncbi.nlm.nih.gov/pubmed?term=12160976.
95. Takanashi J., Sugita K., Tanabe Y., et al. Dichloroacetate treatment in Leigh syndrome caused by mitochondrial DNA mutation. J Neurol Sci 1997, 145:83-86.
96. Lau K.K., Yang S.P., Haddad M.N., et al. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes syndrome with hypothyroidism and focal segmental glomerulosclerosis in a paediatric patient. Int Urol Nephrol 2007, 39:941-946.
97. de Laat P., Koene S., van den Heuvel L.P., et al. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation. J Inherit Metab Dis 2012.
98. Koga Y., Akita Y., Nishioka J., et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005, 64:710-712.
99. Kotagal S., Peterson P.L., Martens M.E., et al. Impaired NADH-CoQ reductase activity in a child with moyamoya syndrome. Pediatr Neurol 1988, 4:241-244.
100. Uimonen S., Moilanen J.S., Sorri M., et al. Hearing impairment in patients with 3243A->G mtDNA mutation: Phenotype and rate of progression. Hum Genet 2001, 108:284-289.
101. Rahman S., Poulton J., Marchington D., et al. Decrease of 3243 A->G mtDNA mutation from blood in MELAS syndrome: A longitudinal study. Am J Hum Genet 2001, 68:238-240.
102. Whittaker R.G., Blackwood J.K., Alston C.L., et al. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology 2009, 72:568-569.
103. Chinnery P.F., Howell N., Lightowlers R.N., et al. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998, 121(Pt 10):1889-1894.
104. Kubota M., Sakakihara Y., Mori M., et al.: Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev 26: 481-483; Discussion 480, 2004.
105. Koga Y., Povalko N., Nishioka J., et al. MELAS and L-arginine therapy: Pathophysiology of stroke-like episodes. Ann N Y Acad Sci 2010, 1201:104-110.
106. El-Hattab A.W., Hsu J.W., Emrick L.T., et al. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet Metab 2012, 105:607-614.
107. Chong P.S., Vucic S., Hedley-Whyte E.T., et al. Multiple Symmetric Lipomatosis (Madelung's Disease) caused by the MERRF (A8344G) mutation: A report of two cases and review of the literature. J Clin Neuromuscul Dis 2003, 5:1-7.
108. Brackmann F., Abicht A., Ahting U., et al. Classical MERRF phenotype associated with mitochondrial tRNA(Leu) (m.3243A>G) mutation. Eur J Pediatr 2012, 171:859-862.
109. Scalais E., Nuttin C., Seneca S., et al. Infantile presentation of the mitochondrial A8344G mutation. Eur J Neurol 2007, 14:e3-5.
110. Santorelli F.M., Mak S.C., El-Schahawi M., et al. Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am J Hum Genet 1996, 58:933-939.
111. Verma A., Piccoli D.A., Bonilla E., et al. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 1997, 42:448-454.
112. Ito S., Shirai W., Asahina M., et al. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol 2008, 29:392-395.
113. Mancuso M., Petrozzi L., Filosto M., et al. MERRF syndrome without ragged-red fibers: The need for molecular diagnosis. Biochem Biophys Res Commun 2007, 354:1058-1060.
114. Chinnery P.F., Elliott C., Green G.R., et al. The spectrum of hearing loss due to mitochondrial DNA defects. Brain 2000, 123(Pt 1):82-92.
115. Prezant T.R., Agapian J.V., Bohlman M.C., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993, 4:289-294.
116. Pandya A., Loss Nonsyndromic Hearing and Deafness, Mitochondrial. GeneReviews 1993, University of Washington, Seattle, WA. R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam (Eds.).
117. ACMG Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet Med 2002, 4:162-171.
118. Nye J.S., Hayes E.A., Amendola M., et al. Myelocystocele-cloacal exstrophy in a pedigree with a mitochondrial 12S rRNA mutation, aminoglycoside-induced deafness, pigmentary disturbances, and spinal anomalies. Teratology 2000, 61:165-171.
119. Sevior K.B., Hatamochi A., Stewart I.A., et al. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998, 75:179-185.
120. Sinnathuray A.R., Raut V., Awa A., et al. A review of cochlear implantation in mitochondrial sensorineural hearing loss. Otol Neurotol 2003, 24:418-426.
121. Holt I.J., Harding A.E., Petty R.K., et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990, 46:428-433.
122. Chowers I., Lerman-Sagie T., Elpeleg O.N., et al. Cone and rod dysfunction in the NARP syndrome. Br J Ophthalmol 1999, 83:190-193.
123. Santorelli F.M., Tanji K., Sano M., et al. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNATrp gene. Ann Neurol 1997, 42:256-260.
124. Haas R.H., Parikh S., Falk M.J., et al. Mitochondrial disease: A practical approach for primary care physicians. Pediatrics 2007, 120:1326-1333.